*Available in 2026, currently undergoing FDA approval
We are developing an accessible, cost-efficient, and accurate diagnostic tool for Type 1 Diabetes.
*Available in 2026, currently undergoing FDA approval process.
Selected as a finalist for the 2024 Innovation Challenge at the American Diabetes Association
Selected as a finalist for the 2024 Innovation Challenge at the American Diabetes Association
Learn More
One-third of type 1 diabetes patients are misdiagnosed and not getting a proper treatment.
Traditionally, it has been thought that type 1 diabetes only affects children. However, a recent study indicated that 50% of cases occur in adulthood.
Read the study
A recent study shows that 38% of type 1 diabetes patients are misdiagnosed as type 2 diabetes.
Read the study
Though autoantibody tests (e.g., GAD) are available, the accuracy of these tests is limited, and their accessibility is also low.
Read the study
Our at-home DNA test would change the situation - it would be an accessible, cost-efficient, and accurate tool to support the right diagnosis.
Order your kit, follow instructions provided.
Mail collected sample back to our lab.
Your report will be ready in about 2 weeks.
Achieved clinical grade accuracy with low cost DNA sequencing data
Established low cost operations / process to deliver the results
Follow the regulations and compliances to make it available for anyone
Accumulate and grow the scientific evidences
Make it accessible for all
Order the test online or through your physician at the clinic
Achieve clinical grade accuracy with low cost sequencing data
Establish low cost operations / process to deliver the results
Follow the regulations and compliances to make it available for anyone
Accumulate and grow the scientific evidences
Go-to-market via doctors / clinics
Make it accessible for all
As T1D Strong, we are solving problems around individuals with Type 1 Diabetes
Stay in touch with the T1D Strong website - we’ll keep you updated.
Collaborative project between
T1D Strong and Genomelink